Zentalis Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-26
- Zentalis Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.20%.
- Zentalis Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.20%, a 116.67% decline from fiscal 2022.
- Zentalis Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 1.20%.
- Zentalis Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.60%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | -0.20% 10-K · filed 2026-03-26 |
| 2023-12-31 | -0.20% 10-K · filed 2026-03-26 |
| 2022-12-31 | 1.20% 10-K · filed 2025-03-26 |
| 2021-12-31 | -0.60% 10-K · filed 2024-02-27 |
| 2020-12-31 | -0.10% 10-K · filed 2023-03-01 |
| 2019-12-31 | 0.00% 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |